December 27, 2013 / 3:27 PM / 5 years ago

BRIEF-Lundbeck gets EU marketing approval for Brintellix

STOCKHOLM, Dec 27 (Reuters) - H Lundbeck A/S : * Lundbeck receives European marketing authorization for brintellix for the

treatment of adults with major depressive episodes * Approval is based on an extensive clinical program including positive efficacy data in 9 short-term studies, including one in the elderly, and one positive relapse-prevention study.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below